Feasibility of single step hysteroscopic myomectomy: fibroid size is the most significant factor based on data from a single centre and surgeon.

IF 1.4 Q3 OBSTETRICS & GYNECOLOGY
Facts Views and Vision in ObGyn Pub Date : 2025-06-27 Epub Date: 2025-05-27 DOI:10.52054/FVVO.2025.10
Ursula Catena, Eleonora La Fera, Diana Giannarelli, Andrea Scalera, Emma Bonetti, Federica Bernardini, Federica Campolo, Francesco Fanfani, Giovanni Scambia
{"title":"Feasibility of single step hysteroscopic myomectomy: fibroid size is the most significant factor based on data from a single centre and surgeon.","authors":"Ursula Catena, Eleonora La Fera, Diana Giannarelli, Andrea Scalera, Emma Bonetti, Federica Bernardini, Federica Campolo, Francesco Fanfani, Giovanni Scambia","doi":"10.52054/FVVO.2025.10","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Uterine fibroids are the most common benign solid neoplasms of the uterus. Hysteroscopy represents the gold standard treatment for submucosal fibroids.</p><p><strong>Objectives: </strong>The aim of this study was to retrospectively analyse all consecutive symptomatic patients diagnosed with the International Federation of Gynecology and Obstetrics G0-G3 fibroids who underwent hysteroscopic myomectomy, to identify factors that may influence the feasibility of single step myomectomy.</p><p><strong>Methods: </strong>The study included all consecutive symptomatic patients, diagnosed with G0-G3 fibroid. Surgical procedure was performed by a single experienced surgeon. All patients underwent postoperative hysteroscopic control 30-40 days after the procedure.</p><p><strong>Main outcomes measures: </strong>Evaluation of feasibility of hysteroscopic myomectomy in a single surgical step.</p><p><strong>Results: </strong>One hundred and twenty-five patients were included. In 97 women (77.6%) the fibroid was removed in one single step; 28 patients (22.4%) had a residual fibroid. Of these patients, in 10 cases (35.7%) the residual fibroid was removed during the office hysteroscopic control, 16 (57.2%) and 2 (7.1%) patients required II- and III-time myomectomy, respectively. 85.6% of patients did not need a second time surgery under general anaesthesia. At univariate and multivariate analysis, diameter was found to be the parameter most related to single-step fibroid removal with <i>P</i>=0.001 and <i>P</i><0.001 respectively. For G0-3 fibroids <3 cm in 72% (66/92) of cases the 15 Fr mini-resectoscope was used with one step myomectomy in 89.4% of cases.</p><p><strong>Conclusions: </strong>In expert hands, single step hysteroscopic myomectomy is feasible for G0-3 fibroids. The possibility to use miniaturized instruments for myomectomy may improve the surgical outcomes and prevent intra- and post-operative complications, in particular uterine perforation by avoiding cervical dilation. Further studies are needed to evaluate the true efficacy of 15 Fr mini-resectoscope in the removal of G0-G3 fibroids <3 cm.</p><p><strong>What is new?: </strong>Hysteroscopic myomectomy in a single surgical step is feasible for G0-G3 fibroids, with diameter being the only independent factor influencing the success of the procedure. In expert hands, the success rate of single step myomectomy by using miniaturized instruments in fibroids ≤3 cm, is 89.4%.</p>","PeriodicalId":46400,"journal":{"name":"Facts Views and Vision in ObGyn","volume":" ","pages":"110-120"},"PeriodicalIF":1.4000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12233117/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Facts Views and Vision in ObGyn","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52054/FVVO.2025.10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Uterine fibroids are the most common benign solid neoplasms of the uterus. Hysteroscopy represents the gold standard treatment for submucosal fibroids.

Objectives: The aim of this study was to retrospectively analyse all consecutive symptomatic patients diagnosed with the International Federation of Gynecology and Obstetrics G0-G3 fibroids who underwent hysteroscopic myomectomy, to identify factors that may influence the feasibility of single step myomectomy.

Methods: The study included all consecutive symptomatic patients, diagnosed with G0-G3 fibroid. Surgical procedure was performed by a single experienced surgeon. All patients underwent postoperative hysteroscopic control 30-40 days after the procedure.

Main outcomes measures: Evaluation of feasibility of hysteroscopic myomectomy in a single surgical step.

Results: One hundred and twenty-five patients were included. In 97 women (77.6%) the fibroid was removed in one single step; 28 patients (22.4%) had a residual fibroid. Of these patients, in 10 cases (35.7%) the residual fibroid was removed during the office hysteroscopic control, 16 (57.2%) and 2 (7.1%) patients required II- and III-time myomectomy, respectively. 85.6% of patients did not need a second time surgery under general anaesthesia. At univariate and multivariate analysis, diameter was found to be the parameter most related to single-step fibroid removal with P=0.001 and P<0.001 respectively. For G0-3 fibroids <3 cm in 72% (66/92) of cases the 15 Fr mini-resectoscope was used with one step myomectomy in 89.4% of cases.

Conclusions: In expert hands, single step hysteroscopic myomectomy is feasible for G0-3 fibroids. The possibility to use miniaturized instruments for myomectomy may improve the surgical outcomes and prevent intra- and post-operative complications, in particular uterine perforation by avoiding cervical dilation. Further studies are needed to evaluate the true efficacy of 15 Fr mini-resectoscope in the removal of G0-G3 fibroids <3 cm.

What is new?: Hysteroscopic myomectomy in a single surgical step is feasible for G0-G3 fibroids, with diameter being the only independent factor influencing the success of the procedure. In expert hands, the success rate of single step myomectomy by using miniaturized instruments in fibroids ≤3 cm, is 89.4%.

Abstract Image

Abstract Image

Abstract Image

单步宫腔镜子宫肌瘤切除术的可行性:基于单一中心和外科医生的数据,肌瘤大小是最重要的因素。
背景:子宫肌瘤是子宫最常见的良性实体瘤。宫腔镜是治疗粘膜下肌瘤的金标准。目的:本研究的目的是回顾性分析所有诊断为国际妇产科联合会G0-G3型肌瘤并行宫腔镜子宫肌瘤切除术的连续症状患者,以确定可能影响单步子宫肌瘤切除术可行性的因素。方法:研究纳入所有连续有症状,诊断为G0-G3肌瘤的患者。手术由一位经验丰富的外科医生进行。所有患者术后30-40天接受宫腔镜检查。主要观察指标:评价宫腔镜子宫肌瘤单步切除的可行性。结果:纳入125例患者。97例(77.6%)妇女的子宫肌瘤一次切除;28例(22.4%)存在肌瘤残留。其中,10例(35.7%)残留肌瘤在宫腔镜控制期间被切除,16例(57.2%)和2例(7.1%)患者分别需要II期和iii期子宫肌瘤切除术。85.6%的患者在全身麻醉下不需要二次手术。在单因素和多因素分析中,直径是与一步切除子宫肌瘤最相关的参数,P=0.001和P。结论:在专家看来,一步宫腔镜子宫肌瘤切除G0-3型子宫肌瘤是可行的。使用小型器械进行子宫肌瘤切除术的可能性可以改善手术效果,防止术中和术后并发症,特别是避免宫颈扩张导致子宫穿孔。需要进一步的研究来评估15fr微型切除镜在切除g3 - g3肌瘤中的真正疗效。:子宫镜下子宫肌瘤切除术对于G0-G3级肌瘤是可行的,直径是影响手术成功的唯一独立因素。在专家手中,在子宫肌瘤≤3cm的情况下,采用小型器械一步切除子宫肌瘤的成功率为89.4%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Facts Views and Vision in ObGyn
Facts Views and Vision in ObGyn OBSTETRICS & GYNECOLOGY-
自引率
15.00%
发文量
59
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信